 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
1 News |  |
- | BIOD-238 / Ipsen, BIOD-250 / Ipsen
New P1 trial: Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog (clinicaltrials.gov) - Mar 13, 2013
P1, N=12, Completed, Sponsor: Biodel